GSC The List

Post Reply
Forum Home > A > ANXIETY/ANXIOLYTIC EFFECTS*+ (Anxiety Reducing) [2013-2015]

[email protected]
Site Owner
Posts: 1174

Effect of dietary fat type on anxiety-like and depression-like behavior in mice (full – 2013)

Endocannabinoid system and mood disorders: Priming a target for new therapies (full – 2013)

Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses (full – 2013)

Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report (full – 2013)

Working memory- and anxiety-related behavioral effects of repeated nicotine as a stressor: the role of cannabinoid receptors. (full– 2013)

Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex (full – 2013)

Cannabinoid facilitation of fear extinction memory recall in humans (full– 2013)

Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade (full – 2013)

Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? (full – 2013)

Does Cannabidiol Protect Against Adverse Psychological Effects of THC? (full – 2013)

Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation (full – 2013)

Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full – 2013)

The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full – 2013)

Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms (abst – 2013)

Cannabidiol enhances consolidation of explicit fear extinction in humans (abst – 2013)

The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (abst – 2013)

Monoacylglycerol lipase inhibition-induced changes in plasma corticosterone levels, anxiety and locomotor activity in male CD1 mice. (abst – 2013)

Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013)

Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats (abst – 2013)

Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability (abst – 2013)

Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats (abst – 2013)

Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor. (abst – 2013)

Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats (abst – 2013)

CB1 receptor signaling regulates social anxiety and memory (abst – 2013)

Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013)

Cannabidiol attenuates the long lasting cognitive deficits and anxiogenic-like behaviors promoted by murine cerebral malaria (abst – 2013) -971c-4daa-8b8c-38c0c63c19ad

Effects of compounds that interfere with the endocannabinoid system on behaviors predictive of anxiolytic and panicolytic activity in the elevated T-maze (abst – 2013)

Modulation of anxiety-like behaviour by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray. (abst – 2013)

The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats (abst – 2013)

Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdale. (abst – 2013)

Effects of palmitoylethanolamide and luteolin in an animal model of anxiety/depression (abst – 2013)

Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats. (abst – 2013)

Continuous central infusion of cannabinoid receptor agonist WIN 55,212-2 decreases maternal care in lactating rats: Consequences for fear conditioning in adulthood males (abst – 2013)

The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae) (abst – 2013)

Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience (abst – 2013)

The endocannabinoid system and its possible role in neurobiology of psychiatric disorders (abst – 2013)

Cannabis use motives and personality risk factors (abst – 2013)

The endocannabinoid system: An emotional buffer in the modulation of memory function (abst – 2013)

Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments (abst – 2013)

Potential new way to treat anxiety (news – 2013)

Terpenes May Improve Effectiveness Of Medical Marijuana (news – 2013)

Therapeutic benefits of cannabis: a patient survey. (full – 2014)

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full – 2014)

Central anandamide deficiency predicts stress-induced anxiety: behavioral reversal through endocannabinoid augmentation (full – 2014)

How Cannabis Causes Paranoia: Using the Intravenous Administration of ∆9-Tetrahydrocannabinol (THC) to Identify Key Cognitive Mechanisms Leading to Paranoia (full – 2014)

Genetic Disruption of 2-Arachidonoylglycerol Synthesis Reveals a Key Role for Endocannabinoid Signaling in Anxiety Modulation. (full – 2014)

Cannabis use and anxiety: is stress the missing piece of the puzzle? (full – 2014)

Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray. (abst – 2014)

Impaired Fear Memory Specificity Associated with Deficient Endocannabinoid Dependent Long-Term Plasticity (abst – 2014)

Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors (abst – 2014)

Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. (abst – 2014)

Stress regulates endocannabinoid-CB1 receptor signaling. (abst – 2014)

β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice. (abst – 2014)

Inhibition of FAAH enzyme by pterostilbene: potential mechanism of anxiolytic action (abst – 2014)

Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain. (abst – 2014)

Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies. (abst – 2014)

Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs (abst – 2014)

Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat (abst – 2014)

Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats (abst – 2014)

Anxiogenic-like effects induced by hemopressin in rats (abst – 2014)

DiffereTranslational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder (abst – 2014)

Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease. (abst – 2014)

Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases. (abst - 2014)

Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat. (abst - 2014)

Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation (abst – 2014)

Mouse Study Sheds Light on Pot’s Anxiety Relief (news – 2014)

Marijuana's anxiety relief effects: Receptors found in emotional hub of brain (news – 2014)

How Black Pepper relieves Cannabis Anxiety (news – 2014)

The surprising everyday ingredient that can reduce pot paranoia (news – 2014)

Activating cannabinoid brain receptors could replace marijuana for anxiety treatment (news – 2014)

Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full – 2015)

Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence (abst – 2015)

Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses (abst – 2015)

Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (abst – 2015)

Differential proteomic analysis of the anti-depressive effects of oleamide in a rat chronic mild stress model of depression (abst – 2015)

Central administration of GPR55 receptor agonist and antagonist modulates anxiety related behaviors in rats (abst – 2015)

March 11, 2015 at 6:52 AM Flag Quote & Reply

This topic is closed, no additional posts are allowed.